
Meftypar 500mg/325mg Tablet
Marketer
Unipure Biotech
Salt Composition
Mefenamic Acid (500mg) + Paracetamol (325mg)
Overview Meftypar 500mg/325mg Tablet
Combiflex 500mg/325mg tablets contain a dual-action formula. This medication effectively reduces fever. It also provides relief from mild to moderate pain associated with headaches, muscle aches, and toothaches. Always take Combiflex 500mg/325mg tablets with food to minimize stomach upset. Dosage will be determined by your physician based on your condition and response to treatment. Strictly adhere to your doctor's prescribed dosage and duration. Commonly reported side effects include nausea, vomiting, diarrhea, dyspepsia, anorexia, and pyrosis. Should any of these side effects worsen or become bothersome, consult your physician. They can offer strategies to mitigate these effects. Prior to commencing treatment, inform your doctor of any pre-existing conditions such as peptic ulcers, gastrointestinal bleeding, hypertension, or cardiovascular, renal, or hepatic impairment. Additionally, disclose all other medications you are currently using, as interactions are possible.
Uses of Meftypar 500mg/325mg Tablet
Alleviating pain and reducing fever
Major Benefits of Meftypar 500mg/325mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 500mg/325mg Meftypar tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Meftypar 500mg/325mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Indigestion
- Loss of appetite
- Heartburn
How to use Meftypar 500mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume the Meftypar 500mg/325mg Tablet with a meal.
How Meftypar 500mg/325mg Tablet works:
Each Meftypar 500mg/325mg tablet combines mefenamic acid and paracetamol to alleviate fever, pain, and inflammation by inhibiting the production of specific inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Meftypar 500mg/325mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Meftypar 500mg/325mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Studies in breastfeeding mothers indicate that the components of Meftypar 500mg/325mg tablets do not transfer to breast milk in clinically relevant quantities, posing no apparent risk to the infant. Therefore, its use while breastfeeding is considered safe.
DrivingUNSAFE
Taking a Meftypar 500mg/325mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Meftypar 500mg/325mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Meftypar 500mg/325mg tablets are unsuitable for individuals with severe kidney disease.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Meftypar 500mg/325mg tablets, as dosage modification may be necessary. Consult your physician for guidance. Meftypar 500mg/325mg tablets are contraindicated for patients experiencing severe or active liver disease.
What if you forget to take Meftypar 500mg/325mg Tablet :
Should you forget to take a Meftypar 500mg/325mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Meftypar 500mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
